Recently, it has been demonstrated that suppressing HDAC2 in the peri-infarct cortex of rodents promotes the motor function recovery at day 8 after stroke, opening a new therapeutic window for the treatment of stroke [18]. Here, HDAC2 is linked to stroke disorder.